drugset / Trial / NCT00447486

A Study of GW842166 in Adults With Osteoarthritis Pain

NCT00447486 ↗

Phase 2 Completed 308 enrolled GlaxoSmithKline
RandomizedSingle-groupDouble-blindTreatment

Summary

The purpose of this study is to determine whether GW842166 is effective in the treatment of osteoarthritis pain of the knee.

Timeline

Start
2007-04
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject GW842166X Small molecule — —

Indications